Identification of Determinants of Glucose-Dependent Insulinotropic Polypeptide Receptor That Interact with N-Terminal Biologically Active Region of the Natural Ligand-Reference-Cited by-同舟云学术

Identification of Determinants of Glucose-Dependent Insulinotropic Polypeptide Receptor That Interact with N-Terminal Biologically Active Region of the Natural Ligand

Published:2010-01-08 Issue:4 Volume:77 Page:547-558
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Yaqub Tahir,Tikhonova Irina G.,Lättig Jens,Magnan Remi,Laval Marie,Escrieut Chantal,Boulègue Cyril,Hewage Chandralal,Fourmy Daniel

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference37 articles.

1. Biology of Incretins: GLP-1 and GIP

2. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors

3. Pair potentials for protein folding: choice of reference states and sensitivity of predicted native states to variations in the interaction schemes;Betancourt;Protein Sci,1999

4. Candidate hormones of the gut. 3. Gastric inhibitory polypeptide (GIP);Brown;Gastroenterology,1974

5. Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors;Journal of Chemical Information and Modeling;2023-07-31

2. Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences;Pharmaceuticals;2022-12-31

3. New Insights into the Structure and Function of Class B1 GPCRs;Endocrine Reviews;2022-12-22

4. In Vivo Imaging of the Pancreas and Gut Hormone Receptors;Nanotechnology for Diabetes Management;2022-09-19

5. Development of a first-in-class unimolecular dual GIP/GLP-2 analogue, GL-0001, for the treatment of bone fragility;2022-07-22